CTCF, a transcriptional regulator that acts on enhancers, promoters, and gene bodies (59), together with other TFs in the lower left quadrant, displays decreased binding activity in both PiD and AD compared to their controls. The gene discussed is CTCF; the disease is Alzheimer disease.